Translational Research Institute (TRI)

Partnering for better health to deliver innovative and life-changing therapeutics and treatments.

TRI Logo_newThe Translational Research Institute (TRI) brings four of the country's pinnacle research facilities together with a strong focus on translating the findings of basic biomedical research into better patient outcomes.

A joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Research and the Princess Alexandra Hospital’s Centres for Health Research, the TRI was established in 2013 with $354 million in funding provided by the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT.

The Institute is the culmination of the collective vision of 2006 Australian of the Year Professor Ian Frazer and Professor Derek Hart, former Director of Mater Research, together with clinicians and scientists from the Diamantina Health Partners, an integrated health sciences centre.

An Australian first, the Institute allows biopharmaceuticals and treatments to be discovered, produced, clinically tested and manufactured in a single location.

Researchers at the TRI aim to discover and develop new treatments and therapies to improve and benefit the health of people worldwide.

Upcoming Events

Mar 07, 2020 - Mar 10, 2020 USANZ 2020 Annual Scientific Meeting
International Convention Centre, Sydney, New South Wales
Mar 20, 2020 - Mar 24, 2020 EAU Congress 2020
RAI Amsterdam, The Netherlands
Mar 25, 2020 - Mar 29, 2020 World Science Festival Brisbane
Mar 28, 2020 - Mar 31, 2020 ENDO 2020
Moscone Center, San Francisco, USA
Apr 24, 2020 - Apr 29, 2020 AACR Annual Meeting 2020
San Diego Convention Center, San Diego, USA